SEC Form 4 · accession 0001209191-15-060716
Tobira Therapeutics, Inc. · TBRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew J. Fromkin
Director
Period of report
Jul 9, 2015
Accepted (ET)
Jul 13, 2015 · 7:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001311596
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F1 | $16.52 | Jul 9, 2015 | A | 15,500 | A | — | Jul 8, 2025 | Common Stock | 15,500 | 15,500 | D |
Explanation of responses
- F1The Reporting Person vests ownership in this option over three years, with 1/36th of the shares subject to the award vesting August 9, 2015, and 1/36th of the shares vesting equally on a monthly basis thereafter, subject to continued service to the Issuer by the Reporting Person.